Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Essity to acquire Kenvue's Brazil business for $284M

PRIVATEAug 22, 2026about 3 hours ago

Acquiring Company

Essity AB (publ)

Acquired Company

Kenvue

SwedenSummitHealth CareHealth Care

Description

Essity AB has announced its acquisition of Kenvue's feminine-care business in Brazil for $284 million. The deal is expected to add 800 million BRL in trailing revenue to Essity's portfolio. This acquisition strengthens Essity's presence in the feminine care market in Brazil. The transaction is anticipated to support future growth in the company's hygiene and health business.

Company Information

Company

Essity AB (publ)

Location

Sweden

About

Essity AB is a leading global hygiene and health company that develops, produces, and sells products within the hygiene and health sectors. The company's portfolio includes well-known brands that provide personal care and health products. Essity aims to improve well-being through sustainable hygiene and health solutions.

Don't miss Essity AB (publ)'s next move

Get an email the moment Essity AB (publ) makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Niklas
Senior decision-maker at this company
••••••••@••••••••

See Niklas's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Essity AB (publ)'s next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Kenvue?

Kenvue was acquired by Essity AB (publ), based in Sweden. The deal was reported on August 22, 2026. Essity AB is a leading global hygiene and health company that develops, produces, and sells products within the hygiene and health sectors. Essity AB (publ) is privately held and operates in Health Care.

When did Essity AB (publ) acquire Kenvue?

Essity AB (publ)'s acquisition of Kenvue was reported on August 22, 2026. Essity AB has announced its acquisition of Kenvue's feminine-care business in Brazil for $284 million. The deal is expected to add 800 million BRL in trailing revenue to Essity's portfolio. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Kenvue do?

Kenvue is a consumer health spinoff of Johnson & Johnson, specializing in global corporate affairs and a portfolio of brands including Band-Aid, Listerine, Tylenol, and Neutrogena. It is publicly traded (KVUE), operating in Health Care, and is based in Summit.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.